Valuation: Vertex Pharmaceuticals Incorporated

Market Cap 126B 111B 102B 95.19B 180B 12,017B 183B 1,229B 476B 5,899B 475B 464B 20,529B P/E 2026 *
28.5x
P/E 2027 * 25.3x
Enterprise Value 114B 99.75B 91.82B 85.56B 161B 10,802B 165B 1,104B 428B 5,302B 427B 417B 18,452B EV / Sales 2026 *
8.71x
EV / Sales 2027 * 7.66x
Free-Float
99.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.26%
1 week+4.80%
Current month+0.26%
1 month+13.60%
3 months+11.35%
6 months+9.85%
Current year+9.85%
1 week 482.2
Extreme 482.2
503.89
1 month 420.01
Extreme 420.01
503.89
Current year 412.27
Extreme 412.27
507.92
1 year 362.5
Extreme 362.5
507.92
3 years 335.82
Extreme 335.82
519.88
5 years 176.36
Extreme 176.36
519.88
10 years 71.46
Extreme 71.46
519.88
Manager TitleAgeSince
Chief Executive Officer 53 31/03/2020
Director of Finance/CFO 58 09/04/2019
Chief Tech/Sci/R&D Officer - 30/06/2021
Director TitleAgeSince
Director/Board Member 66 31/12/1997
Chairman 70 30/04/2012
Director/Board Member 57 17/06/2015
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Chief Technology Officer

-596 0.0002%
06-17Sell

Chief Technology Officer

-1,020 0.0004%
06-14Sell

Chief Technology Officer

-4,062 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+4.80%+10.14%+41.52% 126B
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
+1.81%-0.96%+26.12%+20.22% 324B
+1.75%+0.23%+35.65%+35.86% 285B
+0.86%-0.02%+27.99%+42.29% 283B
-0.66%+2.06%-27.03%-40.49% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average +0.33%+3.02%+25.86%+51.95% 370.71B
Weighted average by Cap. +0.30%+4.18%+37.32%+76.09%

Financials

2026 *2027 *
Net sales 13.04B 11.45B 10.54B 9.82B 18.52B 1,240B 18.89B 127B 49.1B 608B 48.95B 47.89B 2,118B 14.27B 12.53B 11.53B 10.74B 20.26B 1,356B 20.67B 139B 53.73B 666B 53.57B 52.41B 2,317B
Net income 4.45B 3.91B 3.6B 3.35B 6.32B 423B 6.45B 43.27B 16.76B 208B 16.71B 16.35B 723B 5.05B 4.44B 4.08B 3.81B 7.18B 480B 7.32B 49.12B 19.03B 236B 18.97B 18.56B 821B
Net Debt -12.78B -11.22B -10.33B -9.63B -18.16B -1,215B -18.53B -124B -48.15B -597B -48B -46.96B -2,076B -17.13B -15.04B -13.85B -12.9B -24.33B -1,629B -24.83B -167B -64.53B -800B -64.33B -62.94B -2,783B
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
Date Price Change Volume
01/07/26 US$498.01 +0.26% 1,444,535
30/06/26 US$496.73 -0.58% 1,738,335
29/06/26 US$499.65 +1.69% 2,055,780
26/06/26 US$491.34 +2.32% 8,693,047
25/06/26 US$480.18 +1.05% 1,522,567
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
498.01USD
Average target price
548.69USD
Spread / Average Target
+10.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VRTX Stock